SahmAdrangi is the owner of Kerrisdale Capital Management. Kerrisdale is a company which operates from New York and has a net worth of $10 billion. The company raised about $100 million from investors against a single stock. The company’s new co-investment is special. In several occasions, hedge fund managers often raise cash to support a particular investment for example recovery of suffering energy companies or residential mortgage-backed securities. For Kerrisdale Capital, their approach is different. The company plans to use the fund to short stock the upcoming public company. The company raised a given amount of money with a short period frame to finance their campaigns.
Sahm and Shane Wilson, Kerrisdale reputable analyst, reported to be focusing on the upcoming campaign, and hence they worked on video, report, and websites to convince more people about their objective. The target company will be unveiled in May. The funds collected had already started to purchase stock to establish its position in the unnamed company.
Kerrisdale manages about $500 million with the inclusion of the funds collected. The company has a reputable history of betting against enterprises and making its case available to the public. Drug Makers and ZafgenGlobalstar are some of the Kerrisdale short position activists. The company’s hedge fund has an average yearly return of twenty-eight percent, and this has been constant for the last five years. In March 2016, the fund lowered its performance to a tune of seven percent.
Sahm Adramgi is the founder and Chief Investment Officer of Kerrisdale Capital Management. He has developed the company since its initiation in the year 2009 where he started the business with a capital of less than $1 million. He is known for short selling and publishing researchers. He first established himself after shortlisting and exposing fraudulent Chinese companies such as Chinese Marine Food Group, China-Biotics, Lihua International and many others. The shortlisting disclosing occurred in the year 2010 and 2011 consecutively. His company researchers on a variety of companies and industries and majors in the biotechnology sector. Apart from study, Sahm also participated in activism on several investments.
Sahm has also taken part in several conferences such as Sohn conference, Value Investing Conference, Activist Investor Conference, and Distressed Debt Investing Conference as a public speaker. He has also participated in several interviews such as CNBC and Bloomberg and featured in several publications. Sahm studied at Yale University where he obtained a bachelors degree in economics.